Ralph Grosswald - Feb 26, 2024 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role
SVP OF OPERATIONS
Signature
/s/ Greg Duncan, Attorney-in-Fact
Stock symbol
VIRI
Transactions as of
Feb 26, 2024
Transactions value $
$0
Form type
4
Date filed
2/28/2024, 12:47 PM
Previous filing
Dec 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIRI Stock Option (right to buy) Award $0 +62.6K $0.00 62.6K Feb 26, 2024 Common Stock 62.6K $0.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest 100% on February 26, 2025, one year following the grant date.